Addex announces upcoming conferences it will participate for h1 2023

Geneva, switzerland, march 16, 202 3 - addex therapeutics ltd (six: adxn, nasdaq: adxn), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that it will participate in the following conferences during the first half of 2023:

ADXN Ratings Summary

ADXN Quant Ranking